Tools to streamline cell line development for biotherapeutics
Commercialization of a biologic is a lengthy and expensive process. Successful cell line development (CLD) is heavily dependent upon balancing time and resources with acquiring high-quality data for informed decisions. Each stage of the CLD workflow has challenges and there is a real need for advanced strategies and intelligent use of innovative solutions.
The CellCelector, iQue®, Octet®, and Ambr® 15 CC platforms are perfectly designed to seamlessly work together to streamline the early CLD workflow, enabling data-driven decisions and reducing risk during later stages of biologic development. In this webinar, Dr. Fern Slingsby, Ambr Product Specialist at Sartorius and Dr. Daryl Cole, Applications Scientist at Sartorius, will explain how integration of these platforms can be achieved, and where they best fit into the cell line development workflow.
Key learning objectives
- Learn about the early CLD workflow and the bottlenecks associated with the various stages
- Discover instruments which are suited to high-throughput demands and where they fit into the CLD workflow
- Establish a strategy for a simplified approach to cell line development
Who should attend?
- Analytical scientists and researchers involved in early drug discovery and cell line development
- Bioprocessing engineers and scientists
- Process development engineers and scientists
- Lab managers
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Speakers
